Ardelyx, Inc. (ARDX)
3.34
-0.04
(-1.18%)
USD |
NASDAQ |
Oct 02, 16:00
3.335
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Net Income (Quarterly) : -16.72M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.72M |
| March 31, 2026 | -37.60M |
| December 31, 2025 | -0.407M |
| September 30, 2025 | -0.969M |
| June 30, 2025 | -19.08M |
| March 31, 2025 | -41.14M |
| December 31, 2024 | 4.645M |
| September 30, 2024 | -0.809M |
| June 30, 2024 | -16.45M |
| March 31, 2024 | -26.52M |
| December 31, 2023 | -28.80M |
| September 30, 2023 | 6.629M |
| June 30, 2023 | -17.12M |
| March 31, 2023 | -26.77M |
| December 31, 2022 | 10.70M |
| September 30, 2022 | -22.89M |
| June 30, 2022 | -26.94M |
| March 31, 2022 | -28.07M |
| December 31, 2021 | -36.23M |
| September 30, 2021 | -43.59M |
| June 30, 2021 | -45.19M |
| March 31, 2021 | -33.16M |
| December 31, 2020 | -28.88M |
| September 30, 2020 | -18.11M |
| June 30, 2020 | -24.96M |
| Date | Value |
|---|---|
| March 31, 2020 | -22.37M |
| December 31, 2019 | -19.79M |
| September 30, 2019 | -23.54M |
| June 30, 2019 | -25.47M |
| March 31, 2019 | -26.14M |
| December 31, 2018 | -27.86M |
| September 30, 2018 | -24.13M |
| June 30, 2018 | -22.29M |
| March 31, 2018 | -17.02M |
| December 31, 2017 | 10.11M |
| September 30, 2017 | -20.72M |
| June 30, 2017 | -25.72M |
| March 31, 2017 | -28.01M |
| December 31, 2016 | -31.28M |
| September 30, 2016 | -29.03M |
| June 30, 2016 | -28.61M |
| March 31, 2016 | -23.47M |
| December 31, 2015 | -17.00M |
| September 30, 2015 | -18.13M |
| June 30, 2015 | 9.007M |
| March 31, 2015 | -3.502M |
| December 31, 2014 | -3.97M |
| September 30, 2014 | 0.074M |
| June 30, 2014 | 1.614M |
| March 31, 2014 | -0.932M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -40.73M |
| REGENXBIO, Inc. | 22.71M |
| Compass Therapeutics, Inc. | -25.15M |
| ARS Pharmaceuticals, Inc. | -62.34M |
| Sionna Therapeutics, Inc. | -29.89M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 120.88M |
| Total Expenses (Quarterly) | 137.60M |
| EPS Diluted (Quarterly) | -0.0674 |
| Enterprise Value | 806.51M |
| Gross Profit Margin (Quarterly) | 94.74% |
| Profit Margin (Quarterly) | -13.83% |
| Earnings Yield | -6.77% |
| Normalized Earnings Yield | -6.766 |